Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis

Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis

Background: Currently, no tests can definitively diagnose and distinguish neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS). Methods: Initially, cerebrospinal fluid (CSF) proteomics were employed to uncover the novel biomarkers that differentiate NMOSD from MS into cohorts...

Full description

Bibliographic Details
Main Authors: Ting Xu, Yijun Shi, Guanghui Zheng, Guojun Zhang
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Diagnostics
Subjects:
MS
NMOSD
IGFBP7
LAMP2
diagnosis
prediction
Online Access:https://www.mdpi.com/2075-4418/13/9/1572

Internet

https://www.mdpi.com/2075-4418/13/9/1572

Similar Items